FDA Issues Warnings to Companies Illegally Selling Drugs Containing KratomAllbiopro2019-06-27T09:35:17+09:006월 27th, 2019|
Are Contract Research Organizations the Place for Your Life Science Career?Allbiopro2019-06-27T09:34:24+09:006월 27th, 2019|
AbbVie’s Latest Acquisition Offers Solution for ‘Life After Humira’Allbiopro2019-06-27T09:33:32+09:006월 27th, 2019|
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario GuidelinesAllbiopro2019-06-27T09:32:38+09:006월 27th, 2019|
AbbVie keeps May TV focus on Humira, while Gilead spends big on HIV drugsAllbiopro2019-06-27T09:31:45+09:006월 27th, 2019|
After Roche, BMS surprises, what does AbbVie need to do to win FTC clearance for Allergan buy?Allbiopro2019-06-27T09:30:51+09:006월 27th, 2019|
Who’s the next Big Pharma takeout target? Biogen, uniQure, AZ top the list: reportAllbiopro2019-06-27T09:29:56+09:006월 27th, 2019|
Novartis manufacturing agreement cited in Syria controversyAllbiopro2019-06-27T09:29:02+09:006월 27th, 2019|
FDA fast-tracks BI, Lilly’s Jardiance in chronic heart failureAllbiopro2019-06-27T09:28:08+09:006월 27th, 2019|
Analysts rip into AbbVie, Allergan’s $63B deal, citing culture clash, strategy concerns and moreAllbiopro2019-06-27T09:27:15+09:006월 27th, 2019|
Frontier Medicines launches with $67M and biotech veteran Varma as CEOAllbiopro2019-06-27T09:26:20+09:006월 27th, 2019|
Sanifit raises series D, smashing Spanish biotech VC recordAllbiopro2019-06-27T09:25:25+09:006월 27th, 2019|
ImmusanT cans phase 2 celiac trial after interim efficacy reviewAllbiopro2019-06-27T09:24:36+09:006월 27th, 2019|
Encoded Therapeutics bags $104M to propel ‘precision gene therapy’ for Dravet syndromeAllbiopro2019-06-27T09:23:43+09:006월 27th, 2019|
WuXi invests in ADCs again to prep for commercial productsAllbiopro2019-06-27T09:22:49+09:006월 27th, 2019|
Cobra’s Symbiosis relationship making UK cell and gene competitiveAllbiopro2019-06-27T09:21:56+09:006월 27th, 2019|
$63bn Allergan deal: ‘Humira is buying the assets that will replace it’Allbiopro2019-06-27T09:21:00+09:006월 27th, 2019|
